Home Article EnsoData raises $20M

EnsoData raises $20M

By HME News Staff

Updated 10:27 AM CDT, Wed June 25, 2025

Justin Mortara MADISON, Wis. – EnsoData has received $20 million in Series B financing led by Questa Capital to accelerate adoption of its AI-powered sleep medicine solutions.

“Traditional approaches in sleep medicine have left nearly 80% of patients undiagnosed and, of the 20% that are positively diagnosed, only one in two will be successfully treated,” said Justin Mortara, Ph.D., president and CEO of EnsoData. “We need to expand patient access with simpler and more economic testing while embracing new approaches for sleep apnea therapies to improve this reality. EnsoData’s AI solutions are uniquely positioned to do both, and this Series B fundraise will allow us to rapidly scale our commercial team to deliver the next wave of AI-driven health care solutions.”

In addition to Questa Capital, existing investors participated in the Series B, including Zetta Venture Partners, Venture Investors Health Fund, Supermoon Capital and Inspire Medical Systems.

In May, EnsoData added Bobby Cockrill to its commercial team.

“The appointment of Bobby is our first step toward establishing a substantial U.S. commercial team,” said Mortara. “His deep experience in diagnostics and managing strategic sales and sales operations are already having an exciting impact.”